Results

Immutep Ltd.

11/12/2021 | Press release | Distributed by Public on 11/11/2021 18:30

AIPAC final data as expected: Phase III supported with maintaining a Buy Rating (ASX:IMM) (Analysts: Dr Melissa Benson and Dr Shane Storey)